Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
0.280
+0.003 (1.12%)
At close: Nov 4, 2024, 4:00 PM
0.287
+0.007 (2.32%)
After-hours: Nov 4, 2024, 5:34 PM EST
UPC Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
| Market Capitalization | 7 | 3 | 12 | 54 | - | - | |
| Market Cap Growth | -37.29% | -71.81% | -77.13% | - | - | - | |
| Enterprise Value | 2 | -19 | -12 | 20 | - | - | |
| Last Close Price | 0.28 | 0.95 | 3.39 | 14.82 | - | - | |
| PE Ratio | - | -0.56 | -1.41 | 4.14 | - | - | |
| PS Ratio | 0.04 | 0.11 | 0.31 | 1.12 | - | - | |
| PB Ratio | 0.04 | 0.09 | 0.26 | 0.91 | - | - | |
| P/FCF Ratio | -1.28 | 3.22 | -8.74 | -3.45 | - | - | |
| P/OCF Ratio | -1.30 | 3.09 | -9.36 | -26.13 | - | - | |
| EV/Sales Ratio | 0.07 | -0.58 | -0.30 | 0.43 | - | - | |
| EV/EBITDA Ratio | 1.03 | 6.21 | 1.72 | 1.46 | - | - | |
| EV/EBIT Ratio | 0.94 | 5.31 | 1.60 | 1.51 | - | - | |
| EV/FCF Ratio | 0.82 | -17.41 | 8.45 | -1.31 | - | - | |
| Debt / Equity Ratio | 0.24 | 0.14 | 0.08 | 0.07 | 0.13 | 0.20 | |
| Debt / EBITDA Ratio | - | - | - | 0.31 | 0.25 | 0.25 | |
| Debt / FCF Ratio | -1.05 | 5.10 | -2.80 | -0.28 | 0.44 | 0.19 | |
| Asset Turnover | 0.45 | 0.57 | 0.62 | 0.97 | 1.32 | 1.45 | |
| Inventory Turnover | 5.93 | 7.93 | 7.82 | 10.37 | 7.35 | 3.69 | |
| Quick Ratio | 1.25 | 2.13 | 2.60 | 3.36 | 2.62 | 1.76 | |
| Current Ratio | 1.63 | 2.68 | 3.17 | 4.50 | 2.91 | 2.24 | |
| Return on Equity (ROE) | -50.22% | -14.34% | -16.58% | 28.39% | 45.55% | 68.45% | |
| Return on Assets (ROA) | -5.65% | -3.91% | -7.17% | 17.17% | 27.47% | 26.55% | |
| Return on Capital (ROIC) | -8.02% | -4.62% | -8.18% | 19.59% | 33.41% | 44.81% | |
| Earnings Yield | -279.96% | -177.93% | -71.09% | 21.07% | - | - | |
| FCF Yield | -93.87% | 31.06% | -11.44% | -29.01% | - | - | |
| Payout Ratio | 0.00% | - | - | - | - | 211.95% | |
| Buyback Yield / Dilution | -0.29% | - | -14.59% | -18.63% | - | - | |
| Total Shareholder Return | -0.29% | - | -14.59% | -18.63% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.